APA (7th ed.) Citation

Roost, M. S., Potthast, H., Walther, C., García-Arieta, A., Abalos, I., Fernandes, E. A. F., . . . Braddy, A. (2021). Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Roost, Matthias Shona, et al. Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities. Frontiers Media S.A, 2021.

MLA (9th ed.) Citation

Roost, Matthias Shona, et al. Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities. Frontiers Media S.A, 2021.